5 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
Follow NK-LGL Leukemia: new trials by email Literature Review of NK-LGL Leukemia trials Research Report on NK-LGL Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas JAK1 Inhibitor - Lymphoma, T-Cell, NK-LGL Leukemia | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 48 | 2024-12-25 | 2025-11-18 |
| PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas PI3K inhibitor - Lymphoma, T-Cell, NK-LGL Leukemia | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 51 | 2024-08-10 | 2025-08-12 |
| Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia Thalidomide and methotrexate - T-LGL Leukemia, NK-LGL Leukemia | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 48 | 2024-08-10 | 2025-11-18 |
| Registry of the German CLL Study Group CLL, SLL | Recruiting | German CLL Study Group | 8000 | 2013-08-01 | 2025-12-08 | |
| National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia A combined retrospective and prospective observational follow-up - T-LGL Leukemia, NK-LGL Leukemia | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 9999 | 2000-01-01 | 2025-06-17 |
Leukemia, Large Granular Lymphocytic (5) · Lymphoma, T-Cell (2) · Leukemia, Prolymphocytic, B-Cell (1) · Leukemia, Prolymphocytic, T-Cell (1) · Lymphoma, T-Cell, Cutaneous (1) · Mycosis Fungoides (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Leukemia (5) · Leukemia, Lymphoid (5) · Leukemia, T-Cell (5) · Lymphatic Diseases (5) · Lymphoproliferative Disorders (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Leukemia, B-Cell (1) · Leukemia, Prolymphocytic (1)
Methotrexate (1) · Thalidomide (1)
Institute of Hematology & Blood Diseases Hospital, China (4) · German CLL Study Group (1)
China (4) · Germany (1)
Shuhua Yi, Doctor (2) · Michael Hallek, MD (1)